{"transactions":[{"id":948753,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-01-06T21:13:21.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":1962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1962,"derivative":{"exercise_price":772.76,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":1962},"source":{"system":"sec-edgar","filing":"0001225474-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000122547426000002/edgardoc.xml","form_type":"4"}},{"id":948752,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T21:13:21.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":6703,"source":{"system":"sec-edgar","filing":"0001225474-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000122547426000002/edgardoc.xml","form_type":"4"}},{"id":1312108,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-01-06T21:06:04.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":1958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1958,"derivative":{"exercise_price":719.37,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":1958},"source":{"system":"sec-edgar","filing":"0001968202-25-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820225000004/edgardoc.xml","form_type":"4"}},{"id":1312107,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-06T21:06:04.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":6548,"source":{"system":"sec-edgar","filing":"0001968202-25-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820225000004/edgardoc.xml","form_type":"4"}},{"id":1671440,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-01-25T21:18:36.000Z","date":"2024-01-23","kind":"exercise","planned":true,"acquired":false,"shares":2707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 24, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":625.6,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":2707},"source":{"system":"sec-edgar","filing":"0001968202-24-000042","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000042/edgardoc.xml","form_type":"4"}},{"id":1671439,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T21:18:36.000Z","date":"2024-01-23","kind":"sale","planned":true,"acquired":false,"shares":2707,"price":950,"value":2571650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 24, 2023."}],"balance_after":6382,"source":{"system":"sec-edgar","filing":"0001968202-24-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000042/edgardoc.xml","form_type":"4"}},{"id":1671438,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T21:18:36.000Z","date":"2024-01-23","kind":"exercise","planned":true,"acquired":true,"shares":2707,"price":625.6,"value":1693499.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 24, 2023."}],"balance_after":9089,"source":{"system":"sec-edgar","filing":"0001968202-24-000042","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000042/edgardoc.xml","form_type":"4"}},{"id":1689440,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-01-04T21:07:03.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":1607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1607,"derivative":{"exercise_price":888.34,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":1607},"source":{"system":"sec-edgar","filing":"0001968202-24-000023","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000023/edgardoc.xml","form_type":"4"}},{"id":1689439,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:07:03.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":6382,"source":{"system":"sec-edgar","filing":"0001968202-24-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000023/edgardoc.xml","form_type":"4"}},{"id":2027190,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-02-08T21:16:37.000Z","date":"2023-02-06","kind":"exercise","acquired":false,"shares":3613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":482.68,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":3613},"source":{"system":"sec-edgar","filing":"0001883850-23-000046","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000046/edgardoc.xml","form_type":"4"}},{"id":2027189,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-08T21:16:37.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":3613,"price":800,"value":2890400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":6247,"source":{"system":"sec-edgar","filing":"0001883850-23-000046","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000046/edgardoc.xml","form_type":"4"}},{"id":2027188,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-08T21:16:37.000Z","date":"2023-02-06","kind":"exercise","acquired":true,"shares":3613,"price":482.68,"value":1743922.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":9860,"source":{"system":"sec-edgar","filing":"0001883850-23-000046","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000046/edgardoc.xml","form_type":"4"}},{"id":2064245,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-01-05T21:21:00.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1929,"derivative":{"exercise_price":725.89,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":1929},"source":{"system":"sec-edgar","filing":"0001883850-23-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000018/edgardoc.xml","form_type":"4"}},{"id":2064244,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T21:21:00.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":6247,"source":{"system":"sec-edgar","filing":"0001883850-23-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000018/edgardoc.xml","form_type":"4"}},{"id":2311966,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-04-01T20:08:41.000Z","date":"2022-03-30","kind":"exercise","acquired":false,"shares":2431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":374.12,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":2431},"source":{"system":"sec-edgar","filing":"0001883850-22-000032","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000032/edgardoc.xml","form_type":"4"}},{"id":2311965,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-01T20:08:41.000Z","date":"2022-03-30","kind":"sale","acquired":false,"shares":2431,"price":700,"value":1701700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":6082,"source":{"system":"sec-edgar","filing":"0001883850-22-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000032/edgardoc.xml","form_type":"4"}},{"id":2311964,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-01T20:08:41.000Z","date":"2022-03-30","kind":"exercise","acquired":true,"shares":2431,"price":374.12,"value":909485.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":8513,"source":{"system":"sec-edgar","filing":"0001883850-22-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000032/edgardoc.xml","form_type":"4"}},{"id":2445816,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-01-05T21:19:46.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":2707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":2707,"derivative":{"exercise_price":625.6,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":2707},"source":{"system":"sec-edgar","filing":"0001708138-22-000006","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000006/edgardoc.xml","form_type":"4"}},{"id":2445815,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:19:46.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":6082,"source":{"system":"sec-edgar","filing":"0001708138-22-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000006/edgardoc.xml","form_type":"4"}},{"id":2572549,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-09-13T20:01:44.000Z","date":"2021-09-10","kind":"exercise","acquired":false,"shares":2479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":380.95,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":2479},"source":{"system":"sec-edgar","filing":"0001708138-21-000076","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000076/edgardoc.xml","form_type":"4"}},{"id":2572548,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-13T20:01:44.000Z","date":"2021-09-10","kind":"sale","acquired":false,"shares":2479,"price":650,"value":1611350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":5891,"source":{"system":"sec-edgar","filing":"0001708138-21-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000076/edgardoc.xml","form_type":"4"}},{"id":2572547,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-13T20:01:44.000Z","date":"2021-09-10","kind":"exercise","acquired":true,"shares":2479,"price":380.95,"value":944375.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":8370,"source":{"system":"sec-edgar","filing":"0001708138-21-000076","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000076/edgardoc.xml","form_type":"4"}},{"id":2678346,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-08T20:03:08.000Z","date":"2021-06-07","kind":"exercise","acquired":false,"shares":1930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant."}],"balance_after":2431,"derivative":{"exercise_price":374.12,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":1930},"source":{"system":"sec-edgar","filing":"0001237899-21-000008","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000008/edgardoc.xml","form_type":"4"}},{"id":2678345,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T20:03:08.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":1930,"price":525,"value":1013250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":5891,"source":{"system":"sec-edgar","filing":"0001237899-21-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000008/edgardoc.xml","form_type":"4"}},{"id":2678344,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T20:03:08.000Z","date":"2021-06-07","kind":"exercise","acquired":true,"shares":1930,"price":374.12,"value":722051.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":7821,"source":{"system":"sec-edgar","filing":"0001237899-21-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000008/edgardoc.xml","form_type":"4"}},{"id":2923369,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-01-05T21:07:23.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":3613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":3613,"derivative":{"exercise_price":482.68,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":3613},"source":{"system":"sec-edgar","filing":"0001237899-21-000001","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000001/edgardoc.xml","form_type":"4"}},{"id":2923368,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T21:07:23.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":5891,"source":{"system":"sec-edgar","filing":"0001237899-21-000001","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789921000001/edgardoc.xml","form_type":"4"}},{"id":3012061,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-10-06T20:09:33.000Z","date":"2020-10-05","kind":"exercise","acquired":false,"shares":9212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":520.01,"expiration_date":"2026-01-04","underlying":"Common Stock","underlying_shares":9212},"source":{"system":"sec-edgar","filing":"0001237899-20-000043","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000043/edgardoc.xml","form_type":"4"}},{"id":3012060,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T20:09:33.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":9212,"price":600,"value":5527200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":5643,"source":{"system":"sec-edgar","filing":"0001237899-20-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000043/edgardoc.xml","form_type":"4"}},{"id":3012059,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T20:09:33.000Z","date":"2020-10-05","kind":"exercise","acquired":true,"shares":9212,"price":520.01,"value":4790332.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":14855,"source":{"system":"sec-edgar","filing":"0001237899-20-000043","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000043/edgardoc.xml","form_type":"4"}},{"id":3024194,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"exercise","acquired":false,"shares":4960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":2479,"derivative":{"exercise_price":380.95,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":4960},"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024193,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"exercise","acquired":false,"shares":7830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":376.69,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":7830},"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024192,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"exercise","acquired":false,"shares":3784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":371.4,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":3784},"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024191,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-22","kind":"sale","acquired":false,"shares":20,"price":552.36,"value":11047.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":5643,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024190,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"sale","acquired":false,"shares":1530,"price":555.74,"value":850282.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents volume-weighted average price of sales of 1,530 shares of Company stock on September 21, 2020 at prices ranging from $555.51 to $556.04. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price."}],"balance_after":5663,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024189,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"sale","acquired":false,"shares":899,"price":554.82,"value":498783.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents volume-weighted average price of sales of 899 shares of Company stock on September 21, 2020 at prices ranging from $554.32 to $555.22. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price."}],"balance_after":7193,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024188,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"sale","acquired":false,"shares":1101,"price":553.17,"value":609040.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents volume-weighted average price of sales of 1,101 shares of Company stock on September 21, 2020 at prices ranging from $552.69 to $553.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price."}],"balance_after":8092,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024187,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"sale","acquired":false,"shares":513,"price":552.01,"value":283181.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 513 shares of Company stock on September 21, 2020 at prices ranging from $551.69 to $552.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price."}],"balance_after":9193,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024186,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"sale","acquired":false,"shares":1501,"price":551.09,"value":827186.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 1,501 shares of Company stock on September 21, 2020 at prices ranging from $550.64 to $551.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price."}],"balance_after":9706,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024185,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"sale","acquired":false,"shares":1600,"price":550.11,"value":880176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 1,600 shares of Company stock on September 21, 2020 at prices ranging from $549.62 to $550.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price."}],"balance_after":11207,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024184,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"sale","acquired":false,"shares":2600,"price":549.07,"value":1427582.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 2,600 shares of Company stock on September 21, 2020 at prices ranging from $548.62 to $549.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price."}],"balance_after":12807,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024183,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"sale","acquired":false,"shares":3654,"price":548.13,"value":2002867.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 3,654 shares of Company stock on September 21, 2020 at prices ranging from $547.61 to $548.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price."}],"balance_after":15407,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024182,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"sale","acquired":false,"shares":1356,"price":547.28,"value":742111.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 1,356 shares of Company stock on September 21, 2020 at prices ranging from $546.57 to $547.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price."}],"balance_after":19061,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024181,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"sale","acquired":false,"shares":800,"price":546.01,"value":436808.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 800 shares of Company stock on September 21, 2020 at prices ranging from $545.56 to $546.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price."}],"balance_after":20417,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024180,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"sale","acquired":false,"shares":700,"price":544.96,"value":381472.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 700 shares of Company stock on September 21, 2020 at prices ranging from $544.49 to $545.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price."}],"balance_after":21217,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024179,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"sale","acquired":false,"shares":300,"price":543.19,"value":162957.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 300 shares of Company stock on September 21, 2020 at prices ranging from $542.66 to $543.48. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 21, 2020 at each separate price."}],"balance_after":21917,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024178,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"exercise","acquired":true,"shares":7830,"price":376.69,"value":2949482.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":22217,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024177,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"exercise","acquired":true,"shares":4960,"price":380.95,"value":1889512.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":14387,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3024176,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-23T20:00:51.000Z","date":"2020-09-21","kind":"exercise","acquired":true,"shares":3784,"price":371.4,"value":1405377.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":9427,"source":{"system":"sec-edgar","filing":"0001708138-20-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000105/edgardoc.xml","form_type":"4"}},{"id":3049123,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-24T21:19:37.000Z","date":"2020-08-21","kind":"sale","acquired":false,"shares":1000,"price":617.18,"value":617180.0,"ownership":{"direct":true},"balance_after":5643,"source":{"system":"sec-edgar","filing":"0001237899-20-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000036/edgardoc.xml","form_type":"4"}},{"id":3117647,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"exercise","acquired":false,"shares":4838,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":413.33,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":4838},"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117646,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":4838,"derivative":{"exercise_price":413.33,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117645,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":7838,"derivative":{"exercise_price":413.33,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117644,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":200,"price":604.49,"value":120898.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on June 8, 2020 at prices ranging from $604.40 to $604.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price."}],"balance_after":6643,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117643,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":525,"price":603.82,"value":317005.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Represents volume-weighted average price of sales of 525 shares of Company stock on June 8, 2020 at prices ranging from $603.25 to $604.22. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price."}],"balance_after":6843,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117642,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":1196,"price":602.7,"value":720829.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents volume-weighted average price of sales of 1,196 shares of Company stock on June 8, 2020 at prices ranging from $602.15 to $603.00. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price."}],"balance_after":7368,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117641,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":400,"price":601.29,"value":240516.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents volume-weighted average price of sales of 400 shares of Company stock on June 8, 2020 at prices ranging from $600.85 to $601.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price."}],"balance_after":8564,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117640,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":200,"price":600.12,"value":120024.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on June 8, 2020 at prices ranging from $599.66 to $600.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price."}],"balance_after":8964,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117639,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":200,"price":598.07,"value":119614.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":9164,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117638,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":771,"price":597.51,"value":460680.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents volume-weighted average price of sales of 771 shares of Company stock on June 8, 2020 at prices ranging from $597.04 to $597.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price."}],"balance_after":9364,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117637,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":1111,"price":596.47,"value":662678.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 1,111 shares of Company stock on June 8, 2020 at prices ranging from $595.91 to $596.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price."}],"balance_after":10135,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117636,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":700,"price":595.31,"value":416717.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 700 shares of Company stock on June 8, 2020 at prices ranging from $594.86 to $595.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price."}],"balance_after":11246,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117635,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":60,"price":592.46,"value":35547.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":11946,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117634,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":100,"price":590.47,"value":59047.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":12006,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117633,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":200,"price":589.87,"value":117974.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on June 8, 2020 at prices ranging from $589.41 to $590.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price."}],"balance_after":12106,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117632,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":3200,"price":587.88,"value":1881216.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 3,200 shares of Company stock on June 8, 2020 at prices ranging from $587.88 to $587.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price."}],"balance_after":12306,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117631,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":300,"price":587.2,"value":176160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 300 shares of Company stock on June 8, 2020 at prices ranging from $586.80 to $587.48. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price."}],"balance_after":15506,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117630,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":200,"price":585.58,"value":117116.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on June 8, 2020 at prices ranging from $585.75 to $585.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price."}],"balance_after":15806,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117629,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":1175,"price":583.67,"value":685812.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 1,175 shares of Company stock on June 8, 2020 at prices ranging from $583.15 to $584.11. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price."}],"balance_after":16006,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117628,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":200,"price":582.31,"value":116462.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on June 8, 2020 at prices ranging from $581.98 to $582.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 8, 2020 at each separate price."}],"balance_after":17181,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117627,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"sale","acquired":false,"shares":100,"price":580.65,"value":58065.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":17381,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117626,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"exercise","acquired":true,"shares":4838,"price":413.33,"value":1999690.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":17481,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117625,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"exercise","acquired":true,"shares":3000,"price":413.33,"value":1239990.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":12643,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3117624,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T20:05:30.000Z","date":"2020-06-08","kind":"exercise","acquired":true,"shares":3000,"price":413.33,"value":1239990.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":9643,"source":{"system":"sec-edgar","filing":"0001237899-20-000023","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000023/edgardoc.xml","form_type":"4"}},{"id":3129746,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-01T20:02:31.000Z","date":"2020-05-28","kind":"sale","acquired":false,"shares":1000,"price":578.94,"value":578940.0,"ownership":{"direct":true},"balance_after":6643,"source":{"system":"sec-edgar","filing":"0001708138-20-000064","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000064/edgardoc.xml","form_type":"4"}},{"id":3160085,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T20:19:36.000Z","date":"2020-05-06","kind":"sale","acquired":false,"shares":2000,"price":560,"value":1120000.0,"ownership":{"direct":true},"balance_after":7643,"source":{"system":"sec-edgar","filing":"0001237899-20-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000017/edgardoc.xml","form_type":"4"}},{"id":3219052,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-03-10T20:05:39.000Z","date":"2020-03-09","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":33.42,"expiration_date":"2021-01-03","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001237899-20-000014","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000014/edgardoc.xml","form_type":"4"}},{"id":3219051,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-10T20:05:39.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":300,"price":482.82,"value":144846.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 300 shares of Company stock on March 9, 2020 at prices ranging from $482.51 to $482.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 9, 2020 at each separate price."}],"balance_after":9643,"source":{"system":"sec-edgar","filing":"0001237899-20-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000014/edgardoc.xml","form_type":"4"}},{"id":3219050,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-10T20:05:39.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":500,"price":479.21,"value":239605.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 500 shares of Company stock on March 9, 2020 at prices ranging from $479.05 to $479.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 9, 2020 at each separate price."}],"balance_after":9943,"source":{"system":"sec-edgar","filing":"0001237899-20-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000014/edgardoc.xml","form_type":"4"}},{"id":3219049,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-10T20:05:39.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":200,"price":476.16,"value":95232.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 200 shares of Company stock on March 9, 2020 at prices ranging from $476.15 to $476.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 9, 2020 at each separate price."}],"balance_after":10443,"source":{"system":"sec-edgar","filing":"0001237899-20-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000014/edgardoc.xml","form_type":"4"}},{"id":3219048,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-10T20:05:39.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":327,"price":475.31,"value":155426.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 327 shares of Company stock on March 9, 2020 at prices ranging from $475.19 to $475.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 9, 2020 at each separate price."}],"balance_after":10643,"source":{"system":"sec-edgar","filing":"0001237899-20-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000014/edgardoc.xml","form_type":"4"}},{"id":3219047,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-10T20:05:39.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":73,"price":474.88,"value":34666.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":10970,"source":{"system":"sec-edgar","filing":"0001237899-20-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000014/edgardoc.xml","form_type":"4"}},{"id":3219046,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-10T20:05:39.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":100,"price":471.34,"value":47134.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":11043,"source":{"system":"sec-edgar","filing":"0001237899-20-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000014/edgardoc.xml","form_type":"4"}},{"id":3219045,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-10T20:05:39.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":200,"price":470.83,"value":94166.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":11143,"source":{"system":"sec-edgar","filing":"0001237899-20-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000014/edgardoc.xml","form_type":"4"}},{"id":3219044,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-10T20:05:39.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":100,"price":469.8,"value":46980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":11343,"source":{"system":"sec-edgar","filing":"0001237899-20-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000014/edgardoc.xml","form_type":"4"}},{"id":3219043,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-10T20:05:39.000Z","date":"2020-03-09","kind":"sale","acquired":false,"shares":200,"price":468.14,"value":93628.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":11443,"source":{"system":"sec-edgar","filing":"0001237899-20-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000014/edgardoc.xml","form_type":"4"}},{"id":3219042,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-10T20:05:39.000Z","date":"2020-03-09","kind":"exercise","acquired":true,"shares":2000,"price":33.42,"value":66840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":11643,"source":{"system":"sec-edgar","filing":"0001237899-20-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000014/edgardoc.xml","form_type":"4"}},{"id":3283296,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-10T21:45:45.000Z","date":"2020-02-07","kind":"sale","acquired":false,"shares":1000,"price":382.83,"value":382830.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 1,000 shares of Company stock on February 7, 2020 at prices ranging from $382.79 to $382.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2020 at each separate price."}],"balance_after":9643,"source":{"system":"sec-edgar","filing":"0001237899-20-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000007/edgardoc.xml","form_type":"4"}},{"id":3320053,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-01-06T21:03:41.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":4361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":4361,"derivative":{"exercise_price":374.12,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":4361},"source":{"system":"sec-edgar","filing":"0001237899-20-000003","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000003/edgardoc.xml","form_type":"4"}},{"id":3320052,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T21:03:41.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":10643,"source":{"system":"sec-edgar","filing":"0001237899-20-000003","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000003/edgardoc.xml","form_type":"4"}},{"id":3356318,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-12-02T21:03:08.000Z","date":"2019-11-27","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":2000,"derivative":{"exercise_price":33.42,"expiration_date":"2021-01-03","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001237899-19-000027","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789919000027/edgardoc.xml","form_type":"4"}},{"id":3356317,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-02T21:03:08.000Z","date":"2019-11-27","kind":"sale","acquired":false,"shares":1000,"price":370,"value":370000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":10323,"source":{"system":"sec-edgar","filing":"0001237899-19-000027","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789919000027/edgardoc.xml","form_type":"4"}},{"id":3356316,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-02T21:03:08.000Z","date":"2019-11-27","kind":"exercise","acquired":true,"shares":1000,"price":33.42,"value":33420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":11323,"source":{"system":"sec-edgar","filing":"0001237899-19-000027","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789919000027/edgardoc.xml","form_type":"4"}},{"id":3361834,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-11-22T21:07:51.000Z","date":"2019-11-22","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":3000,"derivative":{"exercise_price":33.42,"expiration_date":"2021-01-03","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001237899-19-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789919000020/edgardoc.xml","form_type":"4"}},{"id":3361833,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-11-22T21:07:51.000Z","date":"2019-11-21","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":4000,"derivative":{"exercise_price":33.42,"expiration_date":"2021-01-03","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001237899-19-000020","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789919000020/edgardoc.xml","form_type":"4"}},{"id":3361832,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T21:07:51.000Z","date":"2019-11-22","kind":"sale","acquired":false,"shares":1000,"price":360,"value":360000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":10323,"source":{"system":"sec-edgar","filing":"0001237899-19-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789919000020/edgardoc.xml","form_type":"4"}},{"id":3361831,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T21:07:51.000Z","date":"2019-11-22","kind":"exercise","acquired":true,"shares":1000,"price":33.42,"value":33420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":11323,"source":{"system":"sec-edgar","filing":"0001237899-19-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789919000020/edgardoc.xml","form_type":"4"}},{"id":3361830,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T21:07:51.000Z","date":"2019-11-21","kind":"sale","acquired":false,"shares":1000,"price":350,"value":350000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":10323,"source":{"system":"sec-edgar","filing":"0001237899-19-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789919000020/edgardoc.xml","form_type":"4"}},{"id":3361829,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T21:07:51.000Z","date":"2019-11-21","kind":"exercise","acquired":true,"shares":1000,"price":33.42,"value":33420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":11323,"source":{"system":"sec-edgar","filing":"0001237899-19-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789919000020/edgardoc.xml","form_type":"4"}},{"id":3376922,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":70163,"kind":"person","name":"GOLDSTEIN JOSEPH L","position":1,"cik":"0001225474","reported_name":"GOLDSTEIN JOSEPH L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T22:02:40.000Z","date":"2019-11-08","kind":"sale","acquired":false,"shares":1000,"price":340.44,"value":340440.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 1,000 shares of Company stock on November 8, 2019 at prices ranging from $340.43 to $340.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price."}],"balance_after":10323,"source":{"system":"sec-edgar","filing":"0001237899-19-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789919000018/edgardoc.xml","form_type":"4"}}],"next_cursor":"2019-11-08T22:02:40.000000Z,3376922"}